Among COVID-19 survivors, an increased risk of death, serious illness – Washington University School of Medicine in St Louis wustl.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wustl.edu Daily Mail and Mail on Sunday newspapers.
Major study details numerous long-term effects of COVID-19, pointing to massive health burden
A new study from Washington University School of Medicine in St. Louis shows that even mild cases of COVID-19 increase the risk of death in the six months following diagnosis and that this risk increases with disease severity. The comprehensive study also catalogues the wide-ranging and long-term health problems often triggered by the infection, even among those not hospitalized. (Image: Sara Moser/School of Medicine)
April 22, 2021 SHARE
As the COVID-19 pandemic has progressed, it has become clear that many survivors even those who had mild cases continue to manage a variety of health problems long after the initial infection should have resolved. In what is believed to be the largest comprehensive study of long COVID-19 to date, researchers at Washington University School of Medicine in St. Louis showed that COVID-19 survivors including those not sick enough to be hospitalize
We’ll start with drug pricing:
Pelosi pushes for drug pricing measure amid uncertainty from White House
There are indications the White House is dropping health care measures from its American Families Plan set to be unveiled next week, and not all Democrats are happy about it.
Among those pushing for the inclusion of a measure to lower drug prices is Speaker Nancy Pelosi (D-Calif.).
House Democrats on Thursday reintroduced their signature legislation to lower drug prices, known as H.R. 3, and Pelosi pointedly noted in a statement that including it in Biden s proposal is important for Democratic lawmakers. The measure would allow the secretary of Health and Human Services to negotiate lower drug prices, a long-held Democratic goal.
E-Mail
IMAGE: A new study from Washington University School of Medicine in St. Louis shows that even mild cases of COVID-19 increase the risk of death in the six months following diagnosis. view more
Credit: Sara Moser
As the COVID-19 pandemic has progressed, it has become clear that many survivors even those who had mild cases continue to manage a variety of health problems long after the initial infection should have resolved. In what is believed to be the largest comprehensive study of long COVID-19 to date, researchers at Washington University School of Medicine in St. Louis showed that COVID-19 survivors including those not sick enough to be hospitalized have an increased risk of death in the six months following diagnosis with the virus.
E-Mail
Almost a year ago, COVID-19 began its global rampage, going on to infect about 69.5 million people and kill about 1.6 million as of early this month. From the beginning, most scientists have said that COVID-19 is deadlier than the seasonal flu, while fringe theories have circulated widely, suggesting it is less deadly or flu s equal.
Evidence is accumulating, however, to show just how much deadlier COVID-19 is compared with the flu and the extent of complications related to the two illnesses.
The new research a deep dive into federal data by researchers at Washington University School of Medicine in St. Louis and Veterans Affairs St. Louis Health Care System reveals a clearer distinction between the two contagious viruses: Among hospitalized patients, COVID-19 was associated with an increased need for ventilators, more admissions into intensive care units (ICUs), longer hospital stays and nearly five times the risk of death than faced by those with the flu.